Individualized Approach to the Management of Coronary Heart Disease: Identifying the Nonresponders Before It Is Too Late
- 27 January 2009
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (4), 331-333
- https://doi.org/10.1016/j.jacc.2008.10.021
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Genetic Determinants of Response to Warfarin during Initial AnticoagulationThe New England Journal of Medicine, 2008
- The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug ResponseClinical Pharmacology & Therapeutics, 2007
- Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor TrialCirculation, 2006
- An association study of 43 SNPs in 16 candidate genes with atorvastatin responseThe Pharmacogenomics Journal, 2005
- C-Reactive Protein Levels and Outcomes after Statin TherapyThe New England Journal of Medicine, 2005
- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Pharmacogenetic Study of Statin Therapy and Cholesterol ReductionJAMA, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesThe New England Journal of Medicine, 2004
- Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation, 2003
- Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemiaThe American Journal of Cardiology, 2002